Summary & Overview
HCPCS Level II M1188: Chronic Kidney Disease Stage 5
HCPCS Level II code M1188 designates patients with chronic kidney disease (CKD) stage 5, identifying a population with advanced renal failure who often require complex care coordination and preparation for renal replacement therapy. Nationally, accurately coding this population is important for clinical tracking, care management programs, and appropriate payment for services related to advanced CKD.
Key payers in the national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how M1188 is used in clinical and billing workflows, typical sites of service where the code appears, and common payer coverage patterns. The publication summarizes benchmarking metrics and policy considerations relevant to billing and documenting CKD stage 5 care, and it provides clinical context for when the code is applicable.
The report does not provide state-specific guidance; it offers national-level context on coding practice, reimbursement relevance, and operational implications for nephrology and dialysis providers. Data not available in the input are clearly noted where applicable.
Billing Code Overview
HCPCS Level II code M1188 identifies patients with a diagnosis of chronic kidney disease (CKD) stage 5. This code captures a clinical population with end-stage kidney disease or very advanced renal failure.
-
Service type: Care management and services tied to advanced chronic kidney disease, including coordination of nephrology care, preparation for renal replacement therapy, and related outpatient or facility-based management.
-
Typical site of service: Outpatient nephrology clinics, dialysis centers, hospital outpatient departments, and other ambulatory settings providing CKD stage 5 care.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old with end-stage renal disease (ESRD) secondary to long-standing diabetes mellitus and hypertension, diagnosed as chronic kidney disease stage 5. The patient presents for evaluation and ongoing management related to ESRD, including modality selection counseling, vascular access assessment, medication reconciliation for renal dosing, and coordination of dialysis services. The clinical workflow begins with the nephrology clinic visit where the nephrologist documents CKD stage 5 (M1188 describes patients with CKD stage 5), reviews recent labs (eGFR, electrolytes, hemoglobin), assesses volume status, and evaluates complications (hyperkalemia, metabolic acidosis, anemia). The clinician determines the need for urgent versus planned dialysis initiation, orders imaging for vascular access planning (e.g., upper extremity duplex for fistula mapping), and coordinates with interventional radiology or vascular surgery for access creation. Education is provided about treatment options (hemodialysis, peritoneal dialysis, transplant referral), and referrals to social work and dialysis centers are documented. Follow-up visits include monitoring access function, medication adjustments, and lab surveillance. Typical site of service is outpatient nephrology clinic or ambulatory dialysis education center; some encounters occur in the hospital when patients require inpatient initiation of dialysis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |